Complete Filing Data
GE HealthCare Technologies Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $10.39 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean GE HealthCare Technologies Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B |
| Selling General And Administrative Expense | $4.23B | $4.27B | $4.28B | $3.63B | $3.56B |
| Research And Development Expense | $1.26B | $1.31B | $1.21B | $1.03B | $816.0M |
| Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax | $422.0M | $456.0M | $897.0M | -$58.0M | -$80.0M |
| Other Comprehensive Income Loss Net Of Tax | -$19.0M | -$691.0M | -$850.0M | -$843.0M | -$198.0M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $418.0M | -$271.0M | $74.0M | -$878.0M | -$326.0M |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | -$16.0M | $36.0M | -$27.0M | -$23.0M | $48.0M |
| Operating Income Loss | $2.76B | $2.63B | $2.44B | $2.52B | $2.80B |
| Operating Expenses | $5.49B | $5.58B | $5.49B | $4.66B | $4.38B |
| Net Income Loss Attributable To Noncontrolling Interest | $70.0M | $57.0M | $46.0M | $51.0M | $46.0M |
| Income Tax Expense Benefit | $614.0M | $531.0M | $743.0M | $563.0M | $600.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $2.77B | $2.58B | $2.36B | $2.51B | $2.88B |
| Gross Profit | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $2.13B | $1.36B | $764.0M | $1.12B | $2.10B |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $60.0M | $53.0M | $9.0M | $51.0M | $46.0M |
| Comprehensive Income Net Of Tax | $2.07B | $1.31B | $755.0M | $1.07B | $2.05B |
| Amortization Of Intangible Assets | $291.0M | $312.0M | $362.0M | $405.0M | $400.0M |
| Revenue From Contract With Customer Excluding Assessed Tax | $20.63B | $19.67B | $19.55B | $18.34B | $17.59B |
| Other Nonoperating Income Expense | $157.0M | $55.0M | $86.0M | $62.0M | $123.0M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$9.0M | -$688.0M | -$813.0M | -$841.0M | -$198.0M |
| Net Income Loss Available To Common Stockholders Basic | $2.08B | $1.99B | $1.39B | $1.92B | $2.25B |
| Income Taxes Paid Net | $429.0M | $491.0M | $474.0M | $851.0M | $615.0M |
| Deferred Income Tax Liabilities Net | $193.0M | $56.0M | $68.0M | $370.0M | |
| Deferred Income Tax Assets Net | $4.49B | $4.47B | $4.47B | $1.55B | |
| Income Loss From Continuing Operations Per Diluted Share | $4.55 | $4.34 | $3.04 | $4.18 | $4.91 |
| Income Loss From Continuing Operations Per Basic Share | $4.56 | $4.37 | $3.06 | $4.18 | $4.91 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $446.0M | $486.0M | $564.0M | $470.0M | $428.0M | $374.0M | $375.0M | $418.0M | $372.0M | $487.0M | $485.0M | $389.0M |
| Selling General And Administrative Expense | $1.05B | $1.03B | $1.04B | $1.03B | $1.07B | $1.04B | $996.0M | $1.07B | $1.06B | $908.0M | $908.0M | $931.0M |
| Research And Development Expense | $292.0M | $302.0M | $344.0M | $316.0M | $327.0M | $324.0M | $322.0M | $298.0M | $270.0M | $260.0M | $257.0M | $238.0M |
| Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax | $29.0M | $79.0M | $69.0M | $67.0M | $36.0M | $35.0M | $264.0M | $18.0M | $65.0M | -$10.0M | -$3.0M | $5.0M |
| Other Comprehensive Income Loss Net Of Tax | -$71.0M | $108.0M | $180.0M | $74.0M | -$58.0M | -$95.0M | -$385.0M | -$5.0M | -$47.0M | -$293.0M | -$478.0M | -$134.0M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$59.0M | $221.0M | $257.0M | $177.0M | -$30.0M | -$76.0M | -$143.0M | $3.0M | $57.0M | -$312.0M | -$472.0M | -$153.0M |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | $17.0M | -$33.0M | -$8.0M | -$36.0M | $8.0M | $16.0M | $22.0M | $10.0M | -$39.0M | $9.0M | -$9.0M | $24.0M |
| Operating Income Loss | $653.0M | $654.0M | $629.0M | $676.0M | $608.0M | $540.0M | $617.0M | $570.0M | $559.0M | $605.0M | $631.0M | $509.0M |
| Operating Expenses | $1.34B | $1.33B | $1.38B | $1.35B | $1.40B | $1.36B | $1.32B | $1.37B | $1.33B | $1.17B | $1.17B | $1.17B |
| Net Income Loss Attributable To Noncontrolling Interest | $18.0M | $14.0M | $24.0M | $19.0M | $7.0M | $14.0M | $7.0M | $15.0M | $11.0M | $6.0M | $13.0M | $13.0M |
| Income Tax Expense Benefit | $179.0M | $113.0M | $104.0M | $168.0M | $143.0M | $124.0M | $250.0M | $137.0M | $163.0M | $129.0M | $153.0M | $131.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $643.0M | $613.0M | $692.0M | $658.0M | $578.0M | $512.0M | $636.0M | $570.0M | $546.0M | $622.0M | $639.0M | $533.0M |
| Gross Profit | $1.99B | $1.99B | $2.01B | $2.03B | $2.00B | $1.90B | $1.94B | $1.94B | $1.89B | $1.77B | $1.80B | $1.68B |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $393.0M | $608.0M | $768.0M | $563.0M | $377.0M | $292.0M | -$3.0M | $428.0M | $336.0M | $200.0M | $20.0M | $268.0M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $13.0M | $14.0M | $24.0M | $19.0M | $7.0M | $14.0M | -$28.0M | $15.0M | $11.0M | $6.0M | $13.0M | $13.0M |
| Comprehensive Income Net Of Tax | $380.0M | $594.0M | $744.0M | $544.0M | $370.0M | $278.0M | $25.0M | $413.0M | $325.0M | $194.0M | $7.0M | $255.0M |
| Amortization Of Intangible Assets | $74.0M | $75.0M | $70.0M | $77.0M | $81.0M | $80.0M | $89.0M | $93.0M | $96.0M | $103.0M | $101.0M | $103.0M |
| Revenue From Contract With Customer Excluding Assessed Tax | $5.14B | $5.01B | $4.78B | $4.86B | $4.84B | $4.65B | $4.82B | $4.82B | $4.71B | $4.58B | $4.48B | $4.34B |
| Other Nonoperating Income Expense | $26.0M | -$1.0M | $99.0M | $9.0M | $1.0M | -$8.0M | $63.0M | $14.0M | $8.0M | $18.0M | $19.0M | $26.0M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$66.0M | $109.0M | $180.0M | $74.0M | -$58.0M | -$95.0M | -$350.0M | -$5.0M | -$47.0M | -$293.0M | ||
| Net Income Loss Available To Common Stockholders Basic | $470.0M | $428.0M | $374.0M | $375.0M | $418.0M | $189.0M | $487.0M | $485.0M | $389.0M | |||
| Income Taxes Paid Net | $91.0M | $86.0M | $102.0M | $203.0M | ||||||||
| Deferred Income Tax Liabilities Net | $171.0M | $173.0M | $159.0M | $59.0M | $55.0M | $68.0M | $62.0M | $81.0M | $64.0M | |||
| Deferred Income Tax Assets Net | $4.47B | $4.52B | $4.46B | $4.31B | $4.37B | $4.41B | $4.28B | $4.35B | $4.34B | |||
| Income Loss From Continuing Operations Per Diluted Share | $1.02 | $0.83 | $0.91 | $1.07 | $1.04 | |||||||
| Income Loss From Continuing Operations Per Basic Share | $1.03 | $0.83 | $0.92 | $1.07 | $1.04 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $10.38B | $8.45B | $7.13B | $9.36B | $16.68B | $14.75B |
| Redeemable Noncontrolling Interest Equity Carrying Amount | $209.0M | $188.0M | $165.0M | $230.0M | $220.0M | $223.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.52B | $2.89B | $2.51B | $1.45B | $561.0M | $1.01B |
| Minority Interest Period Increase Decrease | -$8.0M | $7.0M | $5.0M | -$16.0M | -$3.0M | |
| Interest And Debt Expense | $440.0M | $504.0M | $542.0M | $77.0M | $40.0M | |
| Allowance For Doubtful Accounts Receivable Current | $103.0M | $103.0M | $98.0M | $91.0M | $107.0M | $93.0M |
| Other Operating Activities Cash Flow Statement | -$204.0M | -$83.0M | $151.0M | $140.0M | $11.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.62B | $387.0M | $1.06B | $890.0M | -$451.0M | |
| Redeemable Preferred Stock Dividends | $0.00 | $0.00 | $183.0M | $0.00 | $0.00 | |
| Goodwill | $13.49B | $13.14B | $12.94B | $12.81B | $12.89B | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.39B | -$1.38B | -$691.0M | -$1.88B | ||
| Repayments Of Debt Maturing In More Than Three Months | $1.77B | $1.42B | $855.0M | $3.0M | $10.0M | |
| Other Liabilities Noncurrent | $2.06B | $1.80B | $1.88B | $1.60B | ||
| Other Assets Noncurrent | $2.21B | $1.95B | $1.88B | $1.02B | ||
| Other Assets Current | $726.0M | $532.0M | $389.0M | $417.0M | ||
| Minority Interest | $11.0M | $18.0M | $12.0M | $5.0M | ||
| Long Term Debt Noncurrent | $9.50B | $7.45B | $8.44B | $8.23B | ||
| Liabilities Current | $9.11B | $9.55B | $8.98B | $7.19B | ||
| Liabilities And Stockholders Equity | $36.91B | $33.09B | $32.45B | $27.54B | ||
| Liabilities | $26.31B | $24.44B | $25.14B | $17.95B | ||
| Inventory Net | $2.23B | $1.94B | $1.96B | $2.16B | ||
| Intangible Assets Net Excluding Goodwill | $1.13B | $1.08B | $1.25B | $1.52B | ||
| Contract With Customer Liability Current | $2.10B | $1.94B | $1.92B | $1.90B | ||
| Common Stock Value | $5.0M | $5.0M | $5.0M | $0.00 | ||
| Assets Current | $12.50B | $9.90B | $9.41B | $8.32B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $9.99B | $9.71B | $9.19B | $8.32B | $7.80B | $7.41B | $7.13B | $7.10B | $6.69B | $16.88B | $17.05B | $16.58B |
| Redeemable Noncontrolling Interest Equity Carrying Amount | $204.0M | $220.0M | $211.0M | $177.0M | $177.0M | $177.0M | $161.0M | $209.0M | $201.0M | $198.0M | $220.0M | $229.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.03B | $3.77B | $2.48B | $3.57B | $2.02B | $2.57B | $2.42B | $1.95B | $2.33B | $504.0M | $530.0M | $506.0M |
| Minority Interest Period Increase Decrease | $2.0M | $1.0M | $1.0M | $2.0M | $2.0M | $2.0M | -$1.0M | $3.0M | $2.0M | -$4.0M | $2.0M | $0.00 |
| Interest And Debt Expense | $111.0M | $113.0M | $110.0M | $130.0M | $131.0M | $122.0M | $138.0M | $137.0M | $136.0M | $2.0M | $12.0M | $4.0M |
| Allowance For Doubtful Accounts Receivable Current | $108.0M | $107.0M | $106.0M | $104.0M | $103.0M | $102.0M | $91.0M | $92.0M | $91.0M | |||
| Other Operating Activities Cash Flow Statement | -$101.0M | -$129.0M | -$50.0M | -$27.0M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$416.0M | $59.0M | $883.0M | -$55.0M | ||||||||
| Redeemable Preferred Stock Dividends | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $183.0M | $0.00 | $0.00 | $0.00 | |||
| Goodwill | $13.44B | $13.42B | $13.37B | $13.14B | $13.12B | $12.93B | $12.91B | $12.93B | $12.92B | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.16B | -$1.09B | -$1.20B | -$771.0M | -$845.0M | -$787.0M | -$280.0M | $70.0M | $75.0M | |||
| Repayments Of Debt Maturing In More Than Three Months | $257.0M | $153.0M | $6.0M | $1.0M | ||||||||
| Other Liabilities Noncurrent | $2.10B | $2.01B | $1.84B | $1.92B | $1.80B | $1.81B | $1.83B | $1.93B | $1.83B | |||
| Other Assets Noncurrent | $2.15B | $2.08B | $1.93B | $2.10B | $1.91B | $1.88B | $2.04B | $2.01B | $1.95B | |||
| Other Assets Current | $702.0M | $638.0M | $601.0M | $476.0M | $437.0M | $517.0M | $484.0M | $596.0M | $634.0M | |||
| Minority Interest | $23.0M | $21.0M | $20.0M | $18.0M | $16.0M | $14.0M | $11.0M | $12.0M | $6.0M | |||
| Long Term Debt Noncurrent | $8.28B | $8.27B | $6.76B | $9.31B | $8.23B | $8.25B | $10.25B | $10.23B | $10.23B | |||
| Liabilities Current | $10.07B | $9.75B | $9.97B | $8.67B | $8.32B | $8.86B | $7.57B | $7.58B | $8.24B | |||
| Liabilities And Stockholders Equity | $36.13B | $35.50B | $33.59B | $33.86B | $31.85B | $32.21B | $32.38B | $32.31B | $32.64B | |||
| Liabilities | $25.91B | $25.55B | $24.17B | $25.34B | $23.86B | $24.61B | $25.08B | $24.99B | $25.74B | |||
| Inventory Net | $2.30B | $2.28B | $2.16B | $2.12B | $2.02B | $1.99B | $2.13B | $2.26B | $2.26B | |||
| Intangible Assets Net Excluding Goodwill | $1.16B | $1.22B | $1.24B | $1.13B | $1.20B | $1.17B | $1.33B | $1.42B | $1.49B | |||
| Contract With Customer Liability Current | $2.00B | $1.98B | $1.89B | $1.92B | $1.88B | $1.88B | $1.93B | $2.00B | $2.03B | |||
| Common Stock Value | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | |||
| Assets Current | $11.89B | $11.31B | $9.74B | $10.64B | $8.81B | $9.37B | $9.47B | $9.24B | $9.60B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating Cash Flow * | $1.99B | $1.96B | $2.10B | $2.13B | $1.61B |
| Proceeds From Payments For Other Financing Activities | -$81.0M | -$34.0M | -$49.0M | -$92.0M | -$13.0M |
| Payments To Acquire Businesses Net Of Cash Acquired | $378.0M | $313.0M | $147.0M | $0.00 | $1.48B |
| Payments For Proceeds From Other Investing Activities | $69.0M | $160.0M | -$23.0M | $33.0M | $47.0M |
| Increase Decrease In Inventories | $142.0M | $81.0M | -$111.0M | $402.0M | $435.0M |
| Increase Decrease In Contract With Customer Liability | $81.0M | $68.0M | $26.0M | $138.0M | -$21.0M |
| Increase Decrease In Accounts Payable | $90.0M | $60.0M | -$100.0M | $481.0M | $263.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $66.0M | -$77.0M | -$10.0M | -$3.0M | -$34.0M |
| Share Based Compensation | $130.0M | $125.0M | $114.0M | $67.0M | $76.0M |
| Net Cash Provided By Used In Investing Activities | -$1.05B | -$914.0M | -$558.0M | -$398.0M | -$1.76B |
| Net Cash Provided By Used In Financing Activities | $617.0M | -$573.0M | -$478.0M | -$822.0M | -$263.0M |
| Proceeds From Debt Maturing In More Than Three Months | $2.73B | $995.0M | $2.01B | $8.20B | $5.0M |
| Increase Decrease In Contract With Customer Asset And Deferred Costs | $60.0M | -$3.0M | -$10.0M | $222.0M | -$23.0M |
| Increase Decrease In Accounts And Other Receivables | $216.0M | $157.0M | $173.0M | $231.0M | $1.34B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Operating Cash Flow * | $250.0M | $419.0M | $468.0M | $468.0M |
| Proceeds From Payments For Other Financing Activities | -$6.0M | $7.0M | $5.0M | -$30.0M |
| Payments To Acquire Businesses Net Of Cash Acquired | $269.0M | $0.00 | $127.0M | $0.00 |
| Payments For Proceeds From Other Investing Activities | -$34.0M | $24.0M | -$4.0M | $3.0M |
| Increase Decrease In Inventories | $154.0M | $59.0M | $122.0M | $244.0M |
| Increase Decrease In Contract With Customer Liability | -$68.0M | -$18.0M | $119.0M | $77.0M |
| Increase Decrease In Accounts Payable | $146.0M | $31.0M | $87.0M | $319.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $27.0M | -$19.0M | $8.0M | -$3.0M |
| Share Based Compensation | $22.0M | $34.0M | $24.0M | $19.0M |
| Net Cash Provided By Used In Investing Activities | -$407.0M | -$188.0M | -$266.0M | -$100.0M |
| Net Cash Provided By Used In Financing Activities | -$286.0M | -$153.0M | $673.0M | -$420.0M |
| Proceeds From Debt Maturing In More Than Three Months | $0.00 | $1.0M | $2.00B | $0.00 |
| Increase Decrease In Contract With Customer Asset And Deferred Costs | -$52.0M | -$32.0M | -$12.0M | $34.0M |
| Increase Decrease In Accounts And Other Receivables | -$81.0M | -$165.0M | $22.0M | $139.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 456.0M | 456.0M | 455.0M | 454.0M | 454.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 458.0M | 459.0M | 458.0M | 454.0M | 454.0M |
| Earnings Per Share Diluted | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 |
| Earnings Per Share Basic | $4.56 | $4.37 | $3.05 | $4.22 | $4.95 |
| Common Stock Dividends Per Share Declared | $0.14 | $0.13 | $0.12 | ||
| Common Stock Shares Issued | 458.8M | 457.2M | 455.3M | 100.00 | |
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 456.0M | 457.0M | 457.0M | 457.0M | 457.0M | 456.0M | 455.0M | 455.0M | 454.0M | 454.0M | 454.0M | 454.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 457.0M | 458.0M | 459.0M | 459.0M | 459.0M | 459.0M | 458.0M | 458.0M | 457.0M | 454.0M | 454.0M | 454.0M |
| Earnings Per Share Diluted | $0.98 | $1.06 | $1.23 | $1.02 | $0.93 | $0.81 | $0.82 | $0.91 | $0.41 | $1.07 | $1.07 | $0.86 |
| Earnings Per Share Basic | $0.98 | $1.06 | $1.23 | $1.03 | $0.94 | $0.82 | $0.82 | $0.92 | $0.42 | $1.07 | $1.07 | $0.86 |
| Common Stock Dividends Per Share Declared | $0.07 | $0.04 | $0.03 | $0.03 | $0.03 | $0.03 | $0.06 | |||||
| Common Stock Shares Issued | 458.6M | 458.3M | 458.1M | 457.1M | 456.7M | 456.3M | 455.2M | 454.8M | 454.6M | |||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | |||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component | -$288.0M | -$406.0M | -$382.0M | -$5.0M | $3.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $129.0M | $125.0M | $114.0M | ||
| Interest Paid Net | $522.0M | $550.0M | $570.0M | $0.00 | $21.0M |
| Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash | -$267.0M | -$357.0M | -$332.0M | $9.0M | $25.0M |
| Dividends | $64.0M | $58.0M | $55.0M | ||
| Short Term Borrowings | $508.0M | $1.50B | $1.01B | $15.0M | |
| Pension And Other Postretirement Benefits Expense Employer Contribution Cost | $338.0M | $332.0M | $357.0M | $18.0M | $20.0M |
| Depreciation | $287.0M | $268.0M | $248.0M | $228.0M | $225.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component | -$75.0M | -$73.0M | -$74.0M | -$102.0M | -$101.0M | -$102.0M | -$94.0M | -$123.0M | -$115.0M | -$1.0M | -$1.0M | -$2.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $37.0M | $34.0M | $22.0M | $21.0M | $36.0M | $34.0M | $29.0M | $28.0M | $24.0M | |||
| Interest Paid Net | $78.0M | $55.0M | $42.0M | $0.00 | ||||||||
| Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash | -$70.0M | -$90.0M | -$101.0M | $3.0M | ||||||||
| Dividends | $32.0M | $16.0M | $14.0M | $14.0M | $14.0M | $14.0M | $27.0M | |||||
| Short Term Borrowings | $2.01B | $2.01B | $2.00B | $1.01B | $1.01B | $1.01B | $7.0M | $5.0M | $5.0M | |||
| Pension And Other Postretirement Benefits Expense Employer Contribution Cost | $98.0M | $87.0M | $91.0M | $6.0M | ||||||||
| Depreciation | $66.0M | $68.0M | $61.0M | $56.0M |
Most recent annual filing with the SEC: February 4, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.